Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

PRAX-628 is a Novel, Well-Tolerated, Activity Dependent Sodium Channel Blocker with Potent Anticonvulsant Activity

Treatment Outcomes for Patients With Amyotrophic Lateral Sclerosis Receiving Intravenous Edaravone From a Home and Alternative-Site Infusion Provider

Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects